Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Unilever N.V. (ADR) (NYSE:UN): Are Hedge Funds Right About This Stock?

Unilever N.V. (ADR) (NYSE:UN) was in 15 hedge funds’ portfolio at the end of the fourth quarter of 2012. UN shareholders have witnessed a decrease in activity from the world’s largest hedge funds recently. There were 15 hedge funds in our database with UN positions at the end of the previous quarter.

In the financial world, there are dozens of gauges investors can use to watch their holdings. A pair of the most under-the-radar are hedge fund and insider trading activity. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the elite fund managers can outperform the broader indices by a very impressive margin (see just how much).

Unilever N.V. (ADR) (NYSE:UN)

Just as beneficial, optimistic insider trading sentiment is a second way to break down the stock market universe. There are plenty of incentives for an upper level exec to sell shares of his or her company, but just one, very obvious reason why they would behave bullishly. Various empirical studies have demonstrated the market-beating potential of this method if “monkeys” understand what to do (learn more here).

With these “truths” under our belt, we’re going to take a glance at the key action encompassing Unilever N.V. (ADR) (NYSE:UN).

How are hedge funds trading Unilever N.V. (ADR) (NYSE:UN)?

Heading into 2013, a total of 15 of the hedge funds we track held long positions in this stock, a change of 0% from the previous quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists an “upper tier” of notable hedge fund managers who were increasing their stakes meaningfully.

When looking at the hedgies we track, Tom Russo’s Gardner Russo & Gardner had the most valuable position in Unilever N.V. (ADR) (NYSE:UN), worth close to $316 million, accounting for 4.3% of its total 13F portfolio. Coming in second is Osterweis Capital Management, managed by John Osterweis, which held a $84 million position; the fund has 3.7% of its 13F portfolio invested in the stock. Other peers with similar optimism include Phill Gross and Robert Atchinson’s Adage Capital Management, John A. Levin’s Levin Capital Strategies and Ricky Sandler’s Eminence Capital.

Since Unilever N.V. (ADR) (NYSE:UN) has witnessed falling interest from the smart money, logic holds that there lies a certain “tier” of hedgies that slashed their positions entirely heading into 2013. It’s worth mentioning that Robert Rodriguez and Steven Romick’s First Pacific Advisors LLC dropped the largest stake of all the hedgies we key on, valued at close to $13 million in stock., and Israel Englander of Millennium Management was right behind this move, as the fund said goodbye to about $0 million worth. These moves are important to note, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

How are insiders trading Unilever N.V. (ADR) (NYSE:UN)?

Bullish insider trading is particularly usable when the company in question has seen transactions within the past six months. Over the last 180-day time period, Unilever N.V. (ADR) (NYSE:UN) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

With the results shown by the aforementioned studies, everyday investors should always pay attention to hedge fund and insider trading activity, and Unilever N.V. (ADR) (NYSE:UN) is no exception.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!